These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18774440)

  • 1. Medical management of motor fluctuations.
    Dewey RB
    Neurol Clin; 2008 Aug; 26(3 Suppl):S15-27, v. PubMed ID: 18774440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of early Parkinson's disease. Part 1.
    Simuni T; Lyons KE; Pahwa R; Hauser RA; Comella C; Elmer L; Weintraub D
    Eur Neurol; 2009; 61(4):193-205. PubMed ID: 19176960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Motor fluctuations in Parkinson's disease: the "New frontier" of therapeutic success. A Roche Laboratory seminar].
    d'Anglejan Chatillon J
    Rev Prat; 1989 Mar; 39(8):689-90. PubMed ID: 2727575
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
    Sigwald J
    Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
    [No Abstract]   [Full Text] [Related]  

  • 5. Gabapentin and motor fluctuations in Parkinson's disease.
    Chaná P; de Marinis A; Barrientos N
    Mov Disord; 1997 Jul; 12(4):608. PubMed ID: 9251083
    [No Abstract]   [Full Text] [Related]  

  • 6. Apomorphine: a rapid rescue agent for the management of motor fluctuations in advanced Parkinson disease.
    Kolls BJ; Stacy M
    Clin Neuropharmacol; 2006; 29(5):292-301. PubMed ID: 16960475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of initial pharmacotherapy for Parkinson's disease in the United States.
    Huse DM; Castelli-Haley J; Orsini LS; Lenhart G; Abdalla JA
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):91-7. PubMed ID: 16690994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of levodopa-induced motor complications.
    Stocchi F; Tagliati M; Olanow CW
    Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precoce survey: a new self-assessment patient card for early detection and management of Parkinson disease fluctuations].
    Azulay JP; Durif F; Rogez R; Tranchant C; Bourdeix I; Rerat K
    Rev Neurol (Paris); 2008 Apr; 164(4):354-62. PubMed ID: 18439927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy.
    Kurtis MM; Franch O
    Parkinsonism Relat Disord; 2011 Dec; 17(10):774-6. PubMed ID: 21733737
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
    Santens P; de Noordhout AM;
    Acta Neurol Belg; 2006 Sep; 106(3):137-41. PubMed ID: 17091617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute akinesia or akinetic crisis in Parkinson's disease.
    Thomas A; Iacono D; Luciano AL; Armellino K; Onofrj M
    Neurol Sci; 2003 Oct; 24(3):219-20. PubMed ID: 14598096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Insight: new drugs in development for Parkinson's disease.
    Colosimo C; Fabbrini G; Berardelli A
    Nat Clin Pract Neurol; 2006 Nov; 2(11):600-10. PubMed ID: 17057747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Initial management and adaptation of Parkinson's disease treatment].
    Gérard JM
    Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological strategies for controlling motor fluctuations in Parkinson's disease.
    Ruggieri S; Carta A; Stocchi F; Antonini A; Bellantuono P; Monge A
    Funct Neurol; 1988; 3(4):471-9. PubMed ID: 3072281
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of levodopa.
    Nutt JG
    Mov Disord; 2008; 23 Suppl 3():S580-4. PubMed ID: 18781675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.
    Gerschlager W; Bloem BR
    Mov Disord; 2009 Sep; 24(12):1858-60. PubMed ID: 19514056
    [No Abstract]   [Full Text] [Related]  

  • 20. Levodopa in the early treatment of Parkinson's disease.
    Murata M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.